Dr. David Kyle to Speak at Translational Microbiome Conference 2018
Evolve BioSystems is please to announce that Dr. David Kyle, Evolve Board Chairman and CSO, will be speaking at the upcoming Translational Microbiome Conference, April 18-20 in Boston.
Dr. Kyle will be speaking on Friday, April 19th, in a presentation titled "From Dysbiosis to Recovery in the Infant Gut Microbiome, " where he will be sharing Evolve's latest research on the widespread loss of the keystone symbiont B. infantis in the infant gut.
The conference convenes the top companies in the microbiome space working to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products.
For more information, please visit the conference website.
For more information on Evolve BioSystems, contact:
Tracy Shafizadeh, PhD
Director, Scientific Communications